2024/04/30 17:42:33 | |
---|---|
Price | |
84.30 EUR | |
Difference | 11.95% (9.00) |
ISIN | ES0157261019 |
Symbol | ROVI |
Exchange | London Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3,830 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 84.30 EUR |
High | 84.30 EUR |
Low | 84.30 EUR |
Close (prev. day) | 75.30 EUR |
VWAP | 84.30 EUR |
Volume (pcs) | 48 |
Trading volume | 4,046.40 |
Number of trades | 1 |
Last size | 48 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/10/29 | Global Equity Ratings | ||
2024/10/29 | Aktienempfehlungen Global | ||
2024/10/22 | Global Equity Ratings | ||
2024/10/22 | Aktienempfehlungen Global | ||
2024/10/14 | Aktienempfehlungen Österreich |
2024/04/30 17:42:33 | |
---|---|
Price | |
84.30 EUR | |
Difference | 11.95% (9.00) |
ISIN | ES0157261019 |
Symbol | ROVI |
Exchange | London Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3,830 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 84.30 EUR |
High | 84.30 EUR |
Low | 84.30 EUR |
Close (prev. day) | 75.30 EUR |
VWAP | 84.30 EUR |
Volume (pcs) | 48 |
Trading volume | 4,046.40 |
Number of trades | 1 |
Last size | 48 |
6M | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 0.52 | 0.33 | 0.57 |
Volatility | - | - | 9.21 |
Ø price 5 days | Ø volume 5 days (pcs.) | - EUR (-) |
Ø price 30 days | Ø volume 30 days (pcs.) | - EUR (-) |
Ø price 100 days | Ø volume 100 days (pcs.) | 79.80 EUR (691) |
Ø price 250 days | Ø volume 250 days (pcs.) | 79.80 EUR (280) |
YTD High | date | 84.30 EUR (2024/04/30) |
YTD Low | date | 75.30 EUR (2024/03/06) |
52 Weeks High | date | 84.30 EUR (2024/04/30) |
52 Weeks Low | date | 42.00 EUR (2023/07/21) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/11/01 | 09:05 | 77.80 EUR | 0.00 | 1 |
Tradegate | 2024/11/01 | 09:30 | 77.90 EUR | 0.00 | 5 |
Stuttgart | 2024/11/01 | 09:15 | 77.70 EUR | 0.00 | 3 |
Munich | 2024/11/01 | 08:04 | 78.20 EUR | 0.00 | 1 |
London Stock Exchange | 2024/04/30 | 17:42 | 84.30 EUR | 0.00 | 1 |
Frankfurt | 2024/11/01 | 08:04 | 78.00 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/07/01 | 21:24 | 90.61 USD | 0.02 | 2 |
Duesseldorf | 2024/11/01 | 09:31 | 77.70 EUR | 0.00 | 2 |
Berlin | 2024/11/01 | 08:04 | 78.00 EUR | 0.00 | 1 |
BME Continuous Market | 2024/10/31 | 17:35 | 78.10 EUR | 6.23 | 1,163 |
LABORATORIOS FARMACEÚTICOS ROVI SA |
- - |
Calle José Isbert, 2, Pozuelo de Alarcón - 28223 Madrid |
Telefon: +34-91-021-30-00 |
Fax: +34-91-304-78-81 |
E-mail: rovi@rovi.es |
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain. |
Juan López-Belmonte Encina | Chairman of Managing Board |
Aránzazu Lozano Pirrongelli | Member of Executive Committee |
Beatriz Avila Alcalde | Member of Executive Committee |
Fernando Martínez Garijo | Member of Executive Committee |
Francisco Javier Ángulo García | Member of Executive Committee |
Gabriel Núñez Fernández | Member of Executive Committee |
Ibón Gutierro Adúriz | Member of Executive Committee |
M. Rosario Perucha Perez | Member of Executive Committee |
Marta Campos Martínez | Member of Executive Committee |
Mercedes Benitez del Castillo Sanchez | Member of Executive Committee |
Miguel Angel Castillo Román | Member of Executive Committee |
Iván López-Belmonte Encina | Member of Supervisory Board |
Javier López-Belmonte Encina | Member of Supervisory Board |
Marcos Peña Pinto | Member of Supervisory Board |
Marina del Corral Téllez | Member of Supervisory Board |
María Fátima Báñez García | Member of Supervisory Board |
Teresa Santamaría | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.